Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Equity Ratio (2022 - 2023)

Historic Equity Ratio for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to 0.77.

  • Therapeutics' Equity Ratio fell 1891.3% to 0.77 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.77, marking a year-over-year decrease of 1891.3%. This contributed to the annual value of 0.92 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, Therapeutics' Equity Ratio is 0.77, which was down 1891.3% from 0.78 recorded in Q2 2023.
  • Therapeutics' 5-year Equity Ratio high stood at 0.96 for Q2 2022, and its period low was 0.77 during Q3 2023.